Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Peng Yu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Metabolic Brain Disease|April 14, 2016
TDO as a therapeutic target in brain diseasesCheng-Peng Yu, Ze-Zheng Pan, Da-Ya Luo
Medical Oncology (Northwood, London, England)|March 31, 2017
Targeting TDO in cancer immunotherapyCheng-Peng Yu, Yun-Lei Song, Zheng-Ming Zhu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 23, 2018
The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-AnalysisCheng-Peng Yu, Shu-Fang Fu, Xuan Chen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Metabolic Brain Disease|April 14, 2016
TDO as a therapeutic target in brain diseasesCheng-Peng Yu, Ze-Zheng Pan, Da-Ya Luo
Medical Oncology (Northwood, London, England)|March 31, 2017
Targeting TDO in cancer immunotherapyCheng-Peng Yu, Yun-Lei Song, Zheng-Ming Zhu, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 23, 2018
The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-AnalysisCheng-Peng Yu, Shu-Fang Fu, Xuan Chen, et al.
Pageof 1